Evaluation of Prognostic Factors and Role of Participation in a Randomized Trial or a Prospective Registry in Pediatric and Adolescent Nonmetastatic Medulloblastoma – A Report From the HIT 2000 TrialStefan Dietzsch, Martin Mynarek, Felix Placzek et al.|Advances in Radiation Oncology|2020Cited by 22
Survivors of infant atypical teratoid/rhabdoid tumors present with severely impaired cognitive functions especially for fluid intelligence and visual processing: data from the German brain tumor studiesThomas Traunwieser, Michael C. Frühwald, Elena Loos et al.|Pediatric Blood & Cancer|2024Cited by 8
Perinatally diagnosed congenital craniopharyngiomas in the KRANIOPHARYNGEOM trialsJulia Beckhaus, Hermann L. Müller, Svenja Boekhoff et al.|Endocrine Connections|2023Cited by 6
Pineal anlage tumor: clinical and diagnostic features, and rationales for treatmentDenise Obrecht, Stefan Rutkowski, Elke Pfaff et al.|Journal of Neuro-Oncology|2024Cited by 5
Clinical and molecular characterization of isolated M1 disease in pediatric medulloblastoma: experience from the German HIT-MED studiesDenise Obrecht, Stefan Rutkowski, Martin Mynarek et al.|Journal of Neuro-Oncology|2022Cited by 5